DLD Asset Management »

Atai Life Sciences Nv shares owned by DLD Asset Management

Quarter-by-quarter ownership of Atai Life Sciences Nv (ATAI) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 453k 5.29

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding Atai Life Sciences Nv

Adage Capital Partners GP
Citadel Advisors
Ally Bridge Group
ARK Investment Management
T. Rowe Price Investment Management
Susquehanna International
Millennium Management
Pale Fire Capital SE
Marshall Wace
Moore Capital Management
ADAR1 Capital Management
Jpmorgan Chase & Co
Jane Street
Brown University
D. E. Shaw & Co

View all funds holding Atai Life Sciences Nv